Leadership Overview
Queen's University has 10 executives leading key functions including strategy, information technology, financial administration, and organizational leadership.
Committed to advancing academic excellence and research innovation, Queen's University fosters a transformative environment dedicated to shaping future leaders and addressing complex global challenges through rigorous inquiry and collaborative discovery.
Committed to advancing academic excellence and research innovation, Queen's University fosters a transformative environment dedicated to shaping future leaders and addressing complex global challenges through rigorous inquiry and collaborative discovery.
Leadership Roles at Queen's University
Chris Slubicki - Chief Executive Officer, Bachelor of Applied Science (B A Sc )
Chris Slubicki, the Chief Executive Officer, Bachelor of Applied Science (B A Sc ) at Queen's University, directs the overarching strategic vision and institutional growth. Overseeing high-level academic and research initiatives, the Chief Executive Officer, Bachelor of Applied Science (B A Sc ) ensures alignment with long-term goals regarding clinical trial advancements and national research standards. This leadership role involves coordinating with diverse departments to optimize resource allocation and maintain operational excellence across the Canadian landscape. By driving innovation in cancer research methodologies, Chris Slubicki directly impacts the efficacy of clinical trials and patient outcomes. Furthermore, the Chief Executive Officer, Bachelor of Applied Science (B A Sc ) cultivates partnerships with over 2,100 investigators to expand the reach of research programs. Through consistent focus on institutional integrity and scientific progress, Slubicki secures the future trajectory of the organization.
Dana Nanan - Co-President of QGCS
Dana Nanan, the Co-President of QGCS at Queen's University, drives student-led initiatives focused on professional development within the pharmaceutical and clinical research sectors. Overseeing collaborative projects, the Co-President of QGCS ensures that members gain practical exposure to the complexities of cancer research and drug development. This leadership role involves organizing networking events and educational workshops that bridge the gap between academic theory and industry practice. By fostering connections between students and healthcare professionals, Dana Nanan directly contributes to the pipeline of future talent in the research field. Furthermore, the Co-President of QGCS coordinates with other student leaders to expand the organization's influence across the campus community. Through active engagement and strategic programming, Nanan prepares the next generation of researchers to address the evolving needs of the healthcare industry and clinical trial environments.
Leo Marte - Co President
Leo Marte, the Co President at Queen's University, leads efforts to integrate undergraduate research interests with broader clinical trial objectives. Overseeing the development of outreach programs, the Co President ensures that students understand the critical role of clinical trials in improving cancer treatment outcomes. This leadership role involves managing internal communications and fostering a culture of inquiry among the student body. By facilitating partnerships with research groups, Leo Marte directly supports the mission of engaging families and patients in the research process. Furthermore, the Co President collaborates with faculty advisors to align student activities with the strategic goals of the Canadian Cancer Trials Group. Through consistent advocacy for research excellence, Marte strengthens the connection between academic learning and real-world medical applications, ensuring that students remain focused on impactful contributions to the field.
Tyra Obadan - Founder & Co-President
Tyra Obadan, the Founder & Co-President at Queen's University, establishes the foundational framework for student engagement in clinical research and pharmaceutical connectivity. Overseeing the initial strategic direction, the Founder & Co-President ensures that the organization remains focused on its core mission of bridging academic research with professional clinical practice. This leadership role involves mentoring new members and setting the standard for collaborative research initiatives. By creating a platform for dialogue between students and industry experts, Tyra Obadan directly influences the professional development of future researchers. Furthermore, the Founder & Co-President works to secure partnerships that provide students with unique insights into cancer treatment trials. Through visionary leadership and commitment to the organization's growth, Obadan builds a sustainable environment where students can actively contribute to the advancement of medical knowledge and patient care.
Nnenna Akpulonu - Co-President
Nnenna Akpulonu, the Co-President at Queen's University, directs the operational execution of student-led research advocacy and professional networking events. Overseeing the planning of seminars and industry panels, the Co-President ensures that participants receive high-quality information regarding clinical trial methodologies and cancer research trends. This leadership role involves managing logistics and coordinating with guest speakers to provide valuable insights into the pharmaceutical sector. By facilitating these interactions, Nnenna Akpulonu directly supports the professional growth of students interested in clinical research careers. Furthermore, the Co-President collaborates with other executive members to refine the organization's outreach strategy and increase student participation. Through diligent management and a focus on educational value, Akpulonu ensures that the organization remains a vital resource for those seeking to understand the complexities of modern cancer treatment and clinical trial operations.
Mackenzie O'Donnell - Co-Founder & Co-President, Queens U Pharma Connect
Mackenzie O'Donnell, the Co-Founder & Co-President, Queens U Pharma Connect at Queen's University, architects the strategic partnerships between the university and the pharmaceutical industry. Overseeing the development of networking platforms, the Co-Founder & Co-President, Queens U Pharma Connect ensures that students have direct access to professionals involved in clinical trials. This leadership role involves identifying key industry trends and translating them into actionable learning opportunities for the student body. By fostering these connections, Mackenzie O'Donnell directly enhances the university's role in preparing students for careers in cancer research and drug development. Furthermore, the Co-Founder & Co-President, Queens U Pharma Connect coordinates with faculty to ensure that student initiatives align with the broader research goals of the institution. Through proactive engagement and strategic planning, O'Donnell strengthens the bridge between academic research and the practical needs of the pharmaceutical sector.
Naomie Chen - President
Naomie Chen, the President at Queen's University, provides executive oversight for all student-led initiatives related to clinical research and pharmaceutical connectivity. Overseeing the alignment of organizational goals with the university's research mission, the President ensures that all activities contribute to a deeper understanding of cancer treatment trials. This leadership role involves managing the executive team and representing the organization in high-level discussions with faculty and industry partners. By maintaining a focus on excellence and innovation, Naomie Chen directly supports the development of a research-oriented student culture. Furthermore, the President works to ensure that all programs remain inclusive and accessible to students across various disciplines. Through steady leadership and a commitment to the organization's long-term success, Chen fosters an environment where students can effectively contribute to the advancement of clinical research and patient care.
Jihyun Cho - Co-President
Jihyun Cho, the Co-President at Queen's University, manages the strategic outreach and community engagement efforts for student research initiatives. Overseeing the promotion of clinical trial awareness, the Co-President ensures that the student body remains informed about the latest developments in cancer research. This leadership role involves coordinating with external organizations to host collaborative events that highlight the importance of clinical trials. By driving these engagement efforts, Jihyun Cho directly contributes to the visibility of the university's research mission. Furthermore, the Co-President works with the executive team to evaluate the impact of student programs and identify areas for improvement. Through consistent communication and a focus on community building, Cho strengthens the organization's ability to inspire students to pursue careers in clinical research and contribute to the ongoing efforts to improve cancer treatment outcomes.
Marie-claude Arguin - Associate Vice-Principal (Information Technology Services) and Chief Information Officer
Marie-claude Arguin, the Associate Vice-Principal (Information Technology Services) and Chief Information Officer at Queen's University, architects the digital infrastructure supporting complex clinical research data. Overseeing the integration of secure information systems, the Associate Vice-Principal (Information Technology Services) and Chief Information Officer ensures that investigators at over 85 sites access reliable, real-time data for cancer treatment studies. This leadership role involves managing cybersecurity protocols and data privacy standards essential for sensitive medical research. By modernizing technological frameworks, Marie-claude Arguin directly supports the efficiency of the Canadian Cancer Trials Group. Furthermore, the Associate Vice-Principal (Information Technology Services) and Chief Information Officer collaborates with administrative teams to streamline digital workflows across the national network. Through robust technical oversight, Arguin maintains the integrity of the research ecosystem while facilitating seamless communication between healthcare professionals and researchers.
Patrick Legresley - Chief Financial & Administrative Officer
Patrick Legresley, the Chief Financial & Administrative Officer at Queen's University, manages the fiscal health and operational logistics of national clinical trial programs. Overseeing budget allocation for diverse cancer research projects, the Chief Financial & Administrative Officer ensures that financial resources support the needs of over 2,100 investigators. This leadership role involves balancing complex funding streams while maintaining strict compliance with institutional and governmental regulations. By optimizing administrative processes, Patrick Legresley directly enhances the capacity for conducting large-scale clinical trials across Canada. Furthermore, the Chief Financial & Administrative Officer coordinates with executive leadership to align financial planning with the mission of improving patient outcomes. Through rigorous fiscal discipline and strategic resource management, Legresley provides the necessary stability for the organization to pursue ambitious research goals and expand the reach of clinical services.
Explore Leadership Teams in Business Services
Southwest Research Institute (SwRI) is a multidisciplinary, independent, nonprofit organization based in San Antonio, Texas, specializing in applied engineering and physical sciences research and development. The institute offers a Fire Test Reports Database that provides clients with access to reports on tested products, although these products are not necessarily verified for public sale. SwRI serves a diverse clientele, including government, industry, and the public, by leveraging innovative science and technology. The organization operates through ten technical divisions, focusing on various research and development initiatives.
Company Leadership AH
WW
BR
JS
With the right ideas and technology, humanity and nature can bring out the best in one another. At Envu, thats our mission. Every day, were finding breakthrough solutions to reduce threats, restore natural spaces, and respond to any challenge with confidence and precision.
Company Leadership GG
DG
GS
ML
Van Andel Institute is a biomedical research and science education organization headquartered in Grand Rapids, Michigan. Founded in 1996, the institute conducts fundamental and translational science to develop treatment strategies for cancer, Parkinson's, and metabolic disorders. It operates through specialized departments in epigenetics, neurodegenerative science, cell biology, metabolism and nutritional programming, and structural biology. The organization serves the broader medical community and the public by translating laboratory discoveries to the clinic and providing K-12 science education and a research-intensive Ph.D. program in molecular and cellular biology via its Graduate School.
Company Leadership

JN
Embrapa (Brazilian Agricultural Research Corporation) is a Brazilian public research institution headquartered in Brasilia, Brazil. Founded in 1973 and linked to the Ministry of Agriculture, Embrapa conducts agricultural research and development to improve productivity, sustainability, and competitiveness of Brazilian agriculture. The organization operates a network of research centers across Brazil.
Company Leadership SM
RC
FO